Centene (CNC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jul, 2026Executive summary
Q2 2025 reported a GAAP diluted loss per share of $(0.51) and adjusted diluted loss per share of $(0.16), reflecting significant headwinds from reduced Marketplace risk adjustment revenue and higher medical costs.
Total revenues for Q2 2025 reached $48.7 billion, up 22% year-over-year, driven by growth in PDP, Marketplace, and Medicaid, as well as Medicaid rate increases and higher premium tax revenue.
Managed care membership declined by 473,000, or 2%, year-over-year, with Medicaid membership down due to redeterminations, while Marketplace membership grew 33% and PDP membership increased 19%.
Management is focused on restoring earnings trajectory, with aggressive actions underway to return Marketplace to profitability in 2026 and improve Medicaid margins.
Medicare Advantage is on track for break-even in 2027, with PDP performance exceeding expectations.
Financial highlights
Q2 2025 premium and service revenue was $42.5 billion, up 18% year-over-year, primarily from PDP and Marketplace growth and Medicaid rate increases.
Full-year 2025 adjusted diluted EPS forecast reduced to $1.75 from $7.25, reflecting significant headwinds in Marketplace and Medicaid.
Marketplace earnings pressured by a $2.4 billion risk adjustment transfer shortfall and higher utilization.
Medicaid HBR reached 94.9% in Q2, driven by behavioral health, home health, and high-cost drugs.
Net loss attributable to shareholders was $(253) million, compared to net income of $1.1 billion in Q2 2024.
Outlook and guidance
2025 adjusted diluted EPS forecast is $1.75, with downside risk to $1.25 if Medicaid trends worsen.
Corrective pricing actions for 2026 Marketplace products are underway, with rate refilings in states covering most membership and 100% of the book targeted for repricing.
Medicaid margins expected to improve as 88% of the book is re-rated between 7/1/2025 and 1/1/2026.
Medicare Advantage remains on track for break-even in 2027, with PDP premiums increased due to IRA-driven cost-sharing changes.
Medicaid and Marketplace membership expected to be pressured by regulatory changes, including the expiration of enhanced APTCs and the One Big Beautiful Bill Act (OBBBA).
Latest events from Centene
- Q2 2026 EPS hit $2.51 on $53.6B revenue, margins improved, and guidance was raised.CNC
Q2 202628 Jul 2026 - 2025 EPS guidance exceeds $7.25, with premium/service revenue at $154–$156B and growth in Duals and ICHRA.CNC
Investor Day 20248 Jul 2026 - 2024 EPS rose 7% to $7.17; 2025 revenue guidance increased by $4B to $158–$160B.CNC
Q4 20248 Jul 2026 - 2026 guidance targets adjusted EPS above $3.00, with margin recovery and debt reduction focus.CNC
Q4 20258 Jul 2026 - Q1 2025 adjusted EPS up 28% to $2.90, revenue up 17% to $46.6B, guidance raised.CNC
Q1 20251 Jul 2026 - Q1 2026 EPS and revenues exceeded expectations, with improved leverage and strong segment results.CNC
Q1 202628 Apr 2026 - Operational disruption in 2025 drives strategic refocus, governance refresh, and margin recovery plans.CNC
Proxy filing26 Mar 2026 - Key votes include director elections, executive pay, auditor ratification, and board chair proposal.CNC
Proxy filing26 Mar 2026 - 2026 EPS guidance reaffirmed; core businesses on track, with focus on fraud prevention and risk adjustment.CNC
Barclays 28th Annual Global Healthcare Conference10 Mar 2026